Mesoestetic Pharma Group S.L.   Report issue

For profit Phase 3
Founded: Barcelona Spain (1985)
Status: No NME R&D (1985)

Organization Overview

First Clinical Trial
2014
NCT02095990
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Mesoestetic Pharma Group S.L.

Active Ingredients

Drugs in Phase 3 Trials (1)

hydroquinone (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Melanosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1